Hildred portfolio | Binx health
Provider of novel digital and point-of-care testing for sexually transmitted infections aimed at driving better compliance and health outcomes.
hildred.comCrawled Oct 31, 2026
Provider of novel digital and point-of-care testing for sexually transmitted infections aimed at driving better compliance and health outcomes.
Provider of breakthrough ultrasound medical imaging technology, transforming patient assessment: welcome to connected medicine.
A preeminent consumer health business uniquely positioned to acquire leading over-the-counter brands.
Leading supplier of natural therapeutic consumer healthcare products.
The company invests in exceptional management teams in healthcare sectors with strong market potential, growth prospects, innovation opportunities, and manageable competition.
Overview of Hildred's portfolio
AleraCare and PURE Healthcare announce intent to merge, aiming to improve patient care, expand infusion services, and lower healthcare costs nationwide.
Hildred portfolio companies AleraCare and Pure Healthcare complete merger, creating leading ambulatory infusion and specialty care platform across 14 states.
AleraCare appointed Joseph Cosgrove as CEO, replacing retiring founder Russ Corvese. The company is merging with PURE Healthcare in Q4 2025 to create a national platform.
MedicoRx Specialty Pharmacy, Vasco Infusion and VascoRx Specialty Pharmacy subsidiaries to now operate under AleraCare brand name
Samit has played key roles in pharma services and supported the growth of several portfolio companies. Previously, he worked at PennantPark Investment Advisers and SunTrust Robinson Humphrey, specializing in healthcare investments.
Latest news from Hildred.
Adrianne Shapira, Managing Director, Consumer Health Strategy at Hildred Capital
Alexandra Aiello, Investor Relations Associate at Hildred Capital
Andrew Goldman, Co-Founder, Managing Partner at Hildred Capital
Aris P. Voulgaris, Vice President of Finance at Hildred Capital
Arya Blourchian, Senior Associate at Hildred Capital
The company’s team consists of diverse subject matter experts with over 30 years of combined experience in building and growing healthcare companies.
The company aims to build future-focused healthcare companies with a positive impact.
The company focuses on building and growing healthcare companies that add value to the healthcare system and improve patient outcomes.
Hildred is a New York City-based private equity investment firm focused on middle-market companies across the world of healthcare.